Amy Conesky

Amy Conesky is an experienced pharmaceutical professional currently serving as a Thought Leader Liaison at Madrigal Pharmaceuticals, focusing on engaging with gastroenterology and hepatology Key Opinion Leaders in New Jersey and New York City for the launch of Rezdiffra. Previously, Amy held roles at Ferring Pharmaceuticals as an Institutional Key Account Manager, where a first-in-class biotherapeutic was successfully launched, and at Biogen as a Strategic Account Manager, contributing to the market preparation for an Alzheimer's therapy. Additional experience includes impactful positions at Amgen, Boehringer Ingelheim, Amylin Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, and Paychex. Amy's educational background includes a Bachelor's degree in Communications and Marketing from Stockton University.